Company News

Galderma Launches New Microencapsulated Benzoyl Peroxide Rx Cream For Rosacea Bumps & Blemishes

Prescription treatment Epsolay has FDA approval.

Author Image

By: Christine Esposito

Editor-in-Chief

Skin health expert Galderma has expanded its prescription skin treatment stable for roasacea, a skin condition that impacts more than 16 million people in the US. The company today announced the availability of Epsolay (benzoyl peroxide) Cream, 5% in the US following approval by the US Food and Drug Administration (FDA) on April 22, 2022. It is the first and only microencapsulated benzoyl peroxide (E-BPO) topical treatment proven to relieve the bumps and blemishes of rosacea and provides rapid, ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters